Increased senescence and reduced functional ability of fetal endothelial progenitor cells in pregnancies complicated by preeclampsia without intrauterine growth restriction

American Journal of Obstetrics and Gynecology

Volumn 199, Issue 3, 2008, Pages 259.e1-259.e7

  Hwang, Han Sung ^a   Maeng, Yong Sun ^a   Park, Yong Won ^a   Koos, Brian J ^b   Kwon, Young Guen ^a   Kim, Young Han ^a  

^a Yonsei University   (South Korea)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

endothelial progenitor cell; preeclampsia; senescence

Indexed keywords

BETA GALACTOSIDASE;

ADULT; ARTICLE; CELL COUNT; CELL DIFFERENTIATION; CELL FUNCTION; CELL ISOLATION; CLINICAL ARTICLE; COLONY FORMING UNIT; CONTROLLED STUDY; ENDOTHELIUM CELL; FEMALE; FETUS CELL; HUMAN; INTRAUTERINE GROWTH RETARDATION; PREECLAMPSIA; PREGNANCY; PRIORITY JOURNAL; SENESCENCE; STAINING; STATISTICAL SIGNIFICANCE; STEM CELL;

EID: 50349092301     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajog.2008.06.060     Document Type: Article

References (25)

1. Asahara T., Murohara T., Sullivan A., Silver M., van der Zee R., Li T., et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science 275 (1997) 964-967
2. Murohara T., Ikeda H., Duan J., Shintani S., Sasaki K., Eguchi H., et al. Transplanted cord blood-derived endothelial progenitor cells augment postnatal neovascularization. J Clin Invest 105 (2000) 1527-1536
3. Vasa M., Fichtlscherer S., Aicher A., Adler K., Urbich C., Martin H., et al. Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Circ Res 89 (2001) E1-E7
4. Tepper O.M., Galiano R.D., Capla J.M., Kalka C., Gagne P.J., Jacobowitz G.R., et al. Human endothelial progenitor cells from type II diabetes exhibit impaired proliferation, adhesion, and incorporation into vascular structures. Circulation 26 (2002) 2781-2786
5. Schmidt-Lucke C., Rossig L., Fichtlscherer S., Vasa M., Britten M., Kämper U., et al. Reduced number of circulating endothelial progenitor cells predicts future cardiovascular events: proof of concept for the clinical importance of endogenous vascular repair. Circulation 111 (2005) 2981-2987
6. Assmus B., Urbich C., Aicher A., Hofmann W.K., Haendeler J., Rössig L., et al. HMG-CoA reductase inhibitors reduce senescence and increase proliferation of endothelial progenitor cells via regulation of cell cycle regulatory genes. Circ Res 92 (2003) 1049-1055
7. Imanishi T., Hano T., Sawamura T., and Nishio I. Oxidized low-density lipoprotein induces endothelial progenitor cell senescence, leading to cellular dysfunction. Clin Exp Pharmacol Physiol 31 (2004) 407-413
8. National High Blood Pressure Education Program Working Group. Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy. Am J Obstet Gynecol 183 (2000) S1-S22
9. Mayhew T.M., Wijesekara J., Baker P.N., and Ong S.S. Morphometric evidence that villous development and fetoplacental angiogenesis are compromised by intrauterine growth restriction but not by pre-eclampsia. Placenta 25 (2004) 829-833
10. Mayhew T.M., Charnock-Jones D.S., and Kaufmann P. Aspects of human fetoplacental vasculogenesis and angiogenesis: III, changes in complicated pregnancies. Placenta 25 (2004) 127-139
11. Resta L., Capobianco C., Marzullo A., Piscitelli D., Sanguedolce F., Schena F.P., et al. Confocal laser scanning microscope study of terminal villi vessels in normal term and pre-eclamptic placentas. Placenta 27 (2006) 735-739
12. Hristov M., Erl W., and Weber P.C. Endothelial progenitor cells: isolation and characterization. Trends Cardiovasc Med 13 (2003) 201-206
13. Itahana K., Campisi J., and Dimri G.P. Methods to detect biomarkers of cellular senescence: the senescence-associated beta-galactosidase assay. Methods Mol Biol 371 (2007) 21-31
14. Dimri G.P., Lee X., Basile G., Acosta M., Scott G., Roskelley C., et al. A biomarker that identifies senescent human cells in culture and aging skin in vivo. Proc Natl Acad Sci U S A 92 (1995) 9363-9367
15. Kwon J.Y., Maeng Y.S., Kwon Y.G., Kim Y.H., Kang M.H., and Park Y.W. Decreased endothelial progenitor cells in umbilical cord blood in severe preeclampsia. Gynecol Obstet Invest 64 (2007) 103-108
16. Sugawara J., Mitsui-Saito M., Hayashi C., Hoshiai T., Senoo M., Chisaka H., et al. Decrease and senescence of endothelial progenitor cells in patients with preeclampsia. J Clin Endocrinol Metab 90 (2005) 5329-5332
17. Yamaguchi J., Kusano K.F., Masuo O., Kawamoto A., Silver M., Murasawa S., et al. Stromal cell-derived factor-1 effects on ex vivo expanded endothelial progenitor cell recruitment for ischemic neovascularization. Circulation 107 (2003) 1322-1328
18. Ceradini D.J., Kulkarni A.R., Callaghan M.J., Tepper O.M., Bastidas N., Kleinman M.E., et al. Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1. Nat Med 10 (2004) 858-864
19. Maynard S.E., Min J.Y., Merchan J., Lim K.H., Li J., Mondal S., et al. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest 111 (2003) 649-658
20. Venkatesha S., Toporsian M., Lam C., Hanai J., Mammoto T., Kim Y.M., et al. Soluble endoglin contributes to the pathogenesis of preeclampsia. Nat Med 12 (2006) 642-649
21. Keelan J.A., Blumenstein M., Helliwell R.J., Sato T.A., Marvin K.W., and Mitchell M.D. Cytokines, prostaglandins and parturition-a review. Placenta 24 (2003) 33-46
22. Hill J.M., Zalos G., Halcox J.P., Schenke W.H., Waclawiw M.A., Quyyumi A.A., et al. Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med 348 (2003) 593-600
23. Loomans C.J., de Koning E.J., Staal F.J., Rookmaaker M.B., Verseyden C., de Boer H.C., et al. Endothelial progenitor cell dysfunction: a novel concept in the pathogenesis of vascular complications of type 1 diabetes. Diabetes 53 (2004) 195-199
24. Tepper O.M., Galiano R.D., Capla J.M., Tepper O.M., Galiano R.D., Capla J.M., et al. Human endothelial progenitor cells from type II diabetics exhibit impaired proliferation, adhesion, and incorporation into vascular structures. Circulation 106 (2002) 2781-2786
25. Xia L., Zhou X.P., Zhu J.H., Xie X.D., Zhang H., Wang X.X., et al. Decrease and dysfunction of endothelial progenitor cells in umbilical cord blood with maternal pre-eclampsia. J Obstet Gynaecol Res 33 (2007) 465-474